1 エグゼクティブ・サマリー
2 序文
2.1 概要
2.2 ステークホルダー
2.3 調査範囲
2.4 調査方法
2.4.1 データマイニング
2.4.2 データ分析
2.4.3 データの検証
2.4.4 リサーチアプローチ
2.5 リサーチソース
2.5.1 一次調査ソース
2.5.2 セカンダリーリサーチソース
2.5.3 前提条件
3 市場動向分析
3.1 はじめに
3.2 推進要因
3.3 抑制要因
3.4 機会
3.5 脅威
3.6 新興市場
3.7 Covid-19の影響
4 ポーターズファイブフォース分析
4.1 供給者の交渉力
4.2 買い手の交渉力
4.3 代替品の脅威
4.4 新規参入の脅威
4.5 競争上のライバル関係
5 在宅医療の世界市場、コンポーネント別
5.1 はじめに
5.2 機器
5.2.1 治療用
5.2.1.1 家庭用点滴ポンプ
5.2.1.2 在宅透析機器
5.2.1.3 インスリン送達装置
5.2.1.4 在宅呼吸療法機器
5.2.1.5 その他の治療薬
5.2.2 診断機器
5.2.2.1 心拍モニター
5.2.2.2 マルチパラ診断モニター
5.2.2.3 糖尿病治療ユニット
5.2.2.4 無呼吸および睡眠モニター
5.2.2.5 血圧モニター
5.2.2.6 ホルターモニター
5.2.2.7 家庭用妊娠・不妊治療キット
5.2.2.8 その他の診断機器
5.2.3 モビリティケア
5.2.3.1 車椅子
5.2.3.2 歩行補助装置
5.2.3.3 家庭用医療家具
5.3 サービス
5.3.1 看護
5.3.2 リハビリテーション療法
5.3.3 ホスピス＆緩和ケア
5.3.4 非熟練介護
5.3.5 呼吸療法
5.3.6 輸液療法
5.3.7 妊娠ケア
5.3.8 その他のサービス
5.4 その他のコンポーネント
6 在宅医療の世界市場、疾患別
6.1 はじめに
6.2 循環器疾患と高血圧症
6.3 糖尿病と腎臓障害
6.4 神経疾患と精神疾患
6.5 呼吸器疾患とCOPD
6.6 母体障害
6.7 移動障害
6.8 癌
6.9 創傷ケア
6.10 その他の適応症
7 在宅医療の世界市場：流通チャネル別
7.1 はじめに
7.2 直接入札
7.3 小売販売
8 在宅医療の世界市場：地域別
8.1 はじめに
8.2 北アメリカ
8.2.1 アメリカ
8.2.2 カナダ
8.2.3 メキシコ
8.3 ヨーロッパ
8.3.1 ドイツ
8.3.2 イギリス
8.3.3 イタリア
8.3.4 フランス
8.3.5 スペイン
8.3.6 その他のヨーロッパ
8.4 アジア太平洋
8.4.1 日本
8.4.2 中国
8.4.3 インド
8.4.4 オーストラリア
8.4.5 ニュージーランド
8.4.6 韓国
8.4.7 その他のアジア太平洋地域
8.5 南アメリカ
8.5.1 アルゼンチン
8.5.2 ブラジル
8.5.3 チリ
8.5.4 その他の南アメリカ地域
8.6 中東/アフリカ
8.6.1 サウジアラビア
8.6.2 アラブ首長国連邦
8.6.3 カタール
8.6.4 南アフリカ
8.6.5 その他の中東/アフリカ地域
9 主要開発
9.1 契約、パートナーシップ、コラボレーション、合弁事業
9.2 買収と合併
9.3 新製品上市
9.4 拡張
9.5 その他の主要戦略
10 企業プロフィール
10.1 Johnson & Johnson Services, Inc.
10.2 Medline Industries, Inc
10.3 GE Healthcare
10.4 Koninklijke Phillips NV.
10.5 Bayer HealthCare
10.6 3M Healthcare
10.7 Omron Healthcare, Inc.
10.8 Linde Healthcare
10.9 B. Braun Melsungen AG
10.10 F.Hoffmann-La Roche, Ltd.
10.11 Genesis Healthcare, Inc.
10.12 Medtronic PLC
10.13 Teleflex, Inc.
10.14 Abbott
10.15 Cardinal Health Inc.
表一覧
表1 在宅医療の世界市場展望、地域別（2022-2030年） （$MN）
表2 在宅医療の世界市場展望、コンポーネント別（2022-2030年） （$MN）
表3 在宅医療の世界市場展望：機器別（2022-2030年） （$MN）
表4 在宅医療の世界市場展望：治療法別（2022-2030年） （$MN）
表5 在宅医療の世界市場展望：診断別（2022-2030年） （$MN）
表6 在宅医療の世界市場展望：移動ケア別（2022-2030年） （$MN）
表7 在宅医療の世界市場展望：サービス別（2022-2030年） （$MN）
表8 在宅医療の世界市場展望：熟練看護サービス別（2022-2030年） （$MN）
表9 在宅医療の世界市場展望：リハビリテーション療法別（2022-2030年） （$MN）
表10 在宅医療の世界市場展望、ホスピス・緩和ケア別 （2022-2030） （$MN）
表11 在宅医療の世界市場展望、未熟練者ケア別 （2022-2030） （$MN）
表12 在宅医療の世界市場展望、呼吸療法別 （2022-2030） （$MN）
表13 在宅医療の世界市場展望、輸液療法別 （2022-2030） （$MN）
表14 在宅医療の世界市場展望、妊娠ケア別 （2022-2030） （$MN）
表15 在宅医療の世界市場展望、その他のサービス別 （2022-2030） （$MN）
表16 在宅医療の世界市場展望：その他のコンポーネント別（2022-2030年） （$MN）
表17 在宅医療の世界市場展望：疾患別 （2022-2030） （$MN）
表18 在宅医療の世界市場展望：心血管障害と高血圧症別 （2022-2030） （$MN）
表19 在宅医療の世界市場展望、糖尿病と腎臓疾患別 （2022-2030） （$MN）
表20 在宅医療の世界市場展望、神経・精神障害別 （2022-2030） （$MN）
表21 在宅医療の世界市場展望、呼吸器疾患とCOPD別 （2022-2030） （$MN）
表22 在宅医療の世界市場展望：母体疾患別（2022〜2030年） （$MN）
表23 在宅医療の世界市場展望、移動障害別 （2022-2030） （$MN）
表24 在宅医療の世界市場展望、癌別 （2022-2030） （$MN）
表25 在宅医療の世界市場展望：創傷ケア別 （2022-2030） （$MN）
表26 在宅医療の世界市場展望：その他の疾患別 （2022-2030） （$MN）
表27 在宅医療の世界市場展望：流通チャネル別（2022-2030年） （$MN）
表28 在宅医療の世界市場展望：直接入札（2022-2030年）別 （$MN）
表29 在宅医療の世界市場展望：小売販売別（2022-2030年） （$MN）
注：北アメリカ、ヨーロッパ、APAC、南アメリカ、中東/アフリカ地域の表も上記と同様に表現しています。
According to the National Association for Home Care & Hospice (NAHC), home healthcare is a vital service that supports the independence and quality of life for millions of Americans by providing necessary medical care and support services in the comfort of their homes.
Market Dynamics:
Driver:
Reduced hospitalization time
There is an increasing need for home rehabilitation and post-acute care services as hospitals are releasing patients earlier in order to control bed capacity and lower healthcare costs. By offering specialized nursing care, rehabilitation therapies, and medical monitoring to patients in their homes, home healthcare promotes continuity of care. Additionally, this method improves recovery outcomes, lowers the chance of readmissions to the hospital, and supports patient-centered care models that prioritize each patient's unique rehabilitation needs and recovery goals.
Restraint:
Shortages in the workforce
There is a severe scarcity of workers in the home healthcare industry, making it difficult to find and keep skilled healthcare workers. Professionals with expertise in home healthcare services, such as therapists, home health aides, and nurses, are in great demand; however, they may be hard to find in some places or face competitive employment markets. Furthermore, a number of factors, such as changing demographics, an aging healthcare workforce, job burnout, and difficulties providing competitive pay and benefits, are causing a shortage of workers.
Opportunity:
Development of management programs for chronic illnesses
There is a chance to grow chronic disease management programs in the home healthcare industry because chronic diseases like diabetes, heart problems, and respiratory disorders are becoming more common. In order to help people with chronic conditions better manage their health and stop the progression of their disease, home healthcare providers can make use of patient education programs, remote monitoring technologies, and personalized care plans. Moreover, providers can meet the increasing demand for individualized long-term care solutions by providing complete disease management and rehabilitation services at home.
Threat:
Pressures from competition and market consolidation
Competitive pressures and market consolidation present threats to smaller or independent home healthcare providers. Larger healthcare organizations, including hospital systems and integrated delivery networks, may leverage economies of scale, technological resources, and established referral networks to dominate the home healthcare market. Additionally, competitive bidding processes and contracting requirements imposed by insurers and government agencies can create barriers to entry for smaller providers, limiting their ability to compete effectively and maintain market share.
Covid-19 Impact:
The COVID-19 pandemic has had a profound impact on the home healthcare market, accelerating its growth and evolution. As healthcare systems worldwide faced unprecedented challenges in managing patient surges and minimizing virus transmission risks, there was a notable shift towards home-based care models. Home healthcare services became essential for delivering non-urgent medical care, monitoring COVID-19 patients in isolation, and supporting individuals recovering from the virus. Furthermore, telehealth and remote monitoring technologies saw rapid adoption to facilitate virtual consultations and disease management, ensuring continuity of care while minimizing exposure risks.
The Cardiovascular Disorder and Hypertension segment is expected to be the largest during the forecast period
The cardiovascular diseases and hypertension segment is expected to hold the largest share of the home healthcare market because of their prevalence and the need for ongoing management outside of traditional hospital settings. Services like blood pressure monitoring, medication administration and lifestyle counseling are included in this category to help manage cardiovascular health. Moreover, the need for home healthcare services catered to these particular needs is rising due to the aging population and the rising incidence of cardiovascular diseases worldwide.
The Retail Sales segment is expected to have the highest CAGR during the forecast period
The retail sales segment in the home healthcare market has shown the highest CAGR, reflecting a significant shift towards consumer-centric healthcare solutions. This segment encompasses the direct sale of medical products and devices to individuals through various retail channels, including pharmacies, online platforms, and specialty stores. Additionally, a number of factors, including an aging population that is increasingly choosing home-based care, retail channels' accessibility and convenience, and rising acceptance of self-care solutions, are contributing to the industry's rapid growth.
Region with largest share:
Due to a rapidly aging population, high healthcare costs, and sophisticated healthcare infrastructure, North America currently holds the largest share of the home healthcare market. Robust investments in home healthcare technologies and services, advantageous reimbursement policies, and strong consumer demand for individualized care solutions all serve to highlight the region's leadership. Furthermore, rising rates of chronic illness and a move toward more affordable healthcare options support the market's expansion. It is anticipated that North America will maintain its position as a leader in home healthcare thanks to constant innovations and initiatives aimed at improving the quality and accessibility of care in home environments.
Region with highest CAGR:
The home healthcare market is growing significantly in the European region, which has the highest CAGR. Numerous factors, such as an aging population, rising healthcare costs, and a move toward patient-centric care models, are responsible for this growth. In order to meet the growing demand for individualized healthcare solutions and to lower hospital admission rates, European nations are investing an increasing amount of money in home healthcare services and infrastructure. Additionally, the region's market is expanding due to supportive government policies, reimbursement structures that encourage home-based care, and the uptake of cutting-edge medical technologies.
Key players in the market
Some of the key players in Home Healthcare market include Johnson & Johnson Services, Inc., Medline Industries, Inc, GE Healthcare, Koninklijke Phillips NV., Bayer HealthCare, 3M Healthcare, Omron Healthcare, Inc., Linde Healthcare, B. Braun Melsungen AG, F.Hoffmann-La Roche, Ltd., Genesis Healthcare, Inc., Medtronic PLC, Teleflex, Inc., Abbott and Cardinal Health Inc.
Key Developments:
In May 2024, Medline announced a new prime vendor partnership with Urology, P.C. – a leading provider of urological services and surgical procedures based in Lincoln, Nebraska. Urology, P.C. operates a state-of-the-art combined medical practice, oncology clinic and surgery center - Urology Surgical Center - in Lincoln and provides services in 18 satellite clinics around the state.
In April 2024, Bayer AG has entered into a long-term supply agreement for renewable energy with Wuppertaler Stadtwerke (WSW), the public utility company of Wuppertal in North Rhein-Westphalia, Germany. Under the agreement, WSW will provide Bayer with over 120 GWh of wind and/or solar power from German wind and solar parks annually, equivalent to the electricity consumption of approximately 30,000 households.
In December 2023, GE Healthcare has entered into a distribution agreement with mobile-first clinical surveillance technology provider, AirStrip to expand AirStrip Cardiology and Patient Monitoring solutions in the US. The mobile application from AirStrip enables clinicians to view clinical data on the web and on mobile devices. It connects with cardiac rhythm strips and 12-lead ECGs, allowing clinicians to monitor numerous patients at the same time and can receive STEMI notifications.
Components Covered:
• Equipment
• Service
• Other Components
Indications Covered:
• Cardiovascular Disorder and Hypertension
• Diabetes and Kidney Disorders
• Neurological and Mental Disorders
• Respiratory Disease and COPD
• Maternal Disorders
• Mobility Disorders
• Cancer
• Wound Care
• Other Indications
Distribution Channels Covered:
• Direct Tenders
• Retail Sales
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Home Healthcare Market, By Component
5.1 Introduction
5.2 Equipment
5.2.1 Therapeutic
5.2.1.1 Home IV Pumps
5.2.1.2 Home Dialysis Equipment
5.2.1.3 Insulin Delivery Devices
5.2.1.4 Home Respiratory Therapy Equipment
5.2.1.5 Other Therapeutics
5.2.2 Diagnostic
5.2.2.1 Heart Rate Monitors
5.2.2.2 Multi Para Diagnostic Monitors
5.2.2.3 Diabetic Care Unit
5.2.2.4 Apnea and Sleep Monitors
5.2.2.5 BP Monitors
5.2.2.6 Holter Monitors
5.2.2.7 Home Pregnancy and Fertility Kits
5.2.2.8 Other Diagnostics
5.2.3 Mobility Care
5.2.3.1 Wheelchair
5.2.3.2 Walking Assist Devices
5.2.3.3 Home Medical Furniture
5.3 Service
5.3.1 Skilled Nursing
5.3.2 Rehabilitation Therapy
5.3.3 Hospice & Palliative Care
5.3.4 Unskilled Care
5.3.5 Respiratory Therapy
5.3.6 Infusion Therapy
5.3.7 Pregnancy Care
5.3.8 Other Services
5.4 Other Components
6 Global Home Healthcare Market, By Indication
6.1 Introduction
6.2 Cardiovascular Disorder and Hypertension
6.3 Diabetes and Kidney Disorders
6.4 Neurological and Mental Disorders
6.5 Respiratory Disease and COPD
6.6 Maternal Disorders
6.7 Mobility Disorders
6.8 Cancer
6.9 Wound Care
6.10 Other Indications
7 Global Home Healthcare Market, By Distribution Channel
7.1 Introduction
7.2 Direct Tenders
7.3 Retail Sales
8 Global Home Healthcare Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Johnson & Johnson Services, Inc.
10.2 Medline Industries, Inc
10.3 GE Healthcare
10.4 Koninklijke Phillips NV.
10.5 Bayer HealthCare
10.6 3M Healthcare
10.7 Omron Healthcare, Inc.
10.8 Linde Healthcare
10.9 B. Braun Melsungen AG
10.10 F.Hoffmann-La Roche, Ltd.
10.11 Genesis Healthcare, Inc.
10.12 Medtronic PLC
10.13 Teleflex, Inc.
10.14 Abbott
10.15 Cardinal Health Inc.
List of Tables
Table 1 Global Home Healthcare Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Home Healthcare Market Outlook, By Component (2022-2030) ($MN)
Table 3 Global Home Healthcare Market Outlook, By Equipment (2022-2030) ($MN)
Table 4 Global Home Healthcare Market Outlook, By Therapeutic (2022-2030) ($MN)
Table 5 Global Home Healthcare Market Outlook, By Diagnostic (2022-2030) ($MN)
Table 6 Global Home Healthcare Market Outlook, By Mobility Care (2022-2030) ($MN)
Table 7 Global Home Healthcare Market Outlook, By Service (2022-2030) ($MN)
Table 8 Global Home Healthcare Market Outlook, By Skilled Nursing (2022-2030) ($MN)
Table 9 Global Home Healthcare Market Outlook, By Rehabilitation Therapy (2022-2030) ($MN)
Table 10 Global Home Healthcare Market Outlook, By Hospice & Palliative Care (2022-2030) ($MN)
Table 11 Global Home Healthcare Market Outlook, By Unskilled Care (2022-2030) ($MN)
Table 12 Global Home Healthcare Market Outlook, By Respiratory Therapy (2022-2030) ($MN)
Table 13 Global Home Healthcare Market Outlook, By Infusion Therapy (2022-2030) ($MN)
Table 14 Global Home Healthcare Market Outlook, By Pregnancy Care (2022-2030) ($MN)
Table 15 Global Home Healthcare Market Outlook, By Other Services (2022-2030) ($MN)
Table 16 Global Home Healthcare Market Outlook, By Other Components (2022-2030) ($MN)
Table 17 Global Home Healthcare Market Outlook, By Indication (2022-2030) ($MN)
Table 18 Global Home Healthcare Market Outlook, By Cardiovascular Disorder and Hypertension (2022-2030) ($MN)
Table 19 Global Home Healthcare Market Outlook, By Diabetes and Kidney Disorders (2022-2030) ($MN)
Table 20 Global Home Healthcare Market Outlook, By Neurological and Mental Disorders (2022-2030) ($MN)
Table 21 Global Home Healthcare Market Outlook, By Respiratory Disease and COPD (2022-2030) ($MN)
Table 22 Global Home Healthcare Market Outlook, By Maternal Disorders (2022-2030) ($MN)
Table 23 Global Home Healthcare Market Outlook, By Mobility Disorders (2022-2030) ($MN)
Table 24 Global Home Healthcare Market Outlook, By Cancer (2022-2030) ($MN)
Table 25 Global Home Healthcare Market Outlook, By Wound Care (2022-2030) ($MN)
Table 26 Global Home Healthcare Market Outlook, By Other Indications (2022-2030) ($MN)
Table 27 Global Home Healthcare Market Outlook, By Distribution Channel (2022-2030) ($MN)
Table 28 Global Home Healthcare Market Outlook, By Direct Tenders (2022-2030) ($MN)
Table 29 Global Home Healthcare Market Outlook, By Retail Sales (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
